p38 map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY

Hypertension

Volumn 37, Issue 2 II, 2001, Pages 574-580

  Touyz, Rhian M ^a   He, Gang ^a   El Mabrouk, Mohammed ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Arterial; Arteries; Hypertension; Hypertrophy; Kinase; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ANTIBODY SPECIFICITY; APOPTOSIS; COLLAGEN SYNTHESIS; CONFERENCE PAPER; ENZYME PHOSPHORYLATION; ENZYME REGULATION; EXTRACELLULAR MATRIX; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

EID: 0035095988     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.37.2.574     Document Type: Conference Paper

References (35)

1. Vascular remodeling
2. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells
3. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human peripheral resistance arteries: Role of extracellular signal-regulated kinases
4. Role of Ang II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats
5. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin II receptor antagonist losartan
6. Effects of a β-blocker or a converting enzyme inhibitor on small arteries in essential hypertension
7. Comparison of effects of the angiotensin converting enzyme inhibitor enalapril and the calcium channel antagonist amlodipine on small artery structure and composition and on endothelial dysfunction in SHR
8. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease
9. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates Ang II-mediated signaling and contraction in SHR vascular smooth muscle cells
10. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
11. Angiotensin II activates collagen I through a mechanism involving the MAP/ER kinase pathway
12. The role of MAP kinase and protein kinase C in fibronectin production in human vascular smooth muscle cells
13. Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: Evidence for an endothelin-mediated mechanism
14. The p38 MAP kinase pathway and its biological function
15. Stimulation of the p38 MAP kinase in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: A role in cardiac myocyte hypertrophy?
16. + exchange and ERK1/2
17. Cell density and contraction regulate p38 MAP kinase-dependent responses in neonatal rat cardiac myocytes
18. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
19. Stimulation of stress-regulated MAP kinases (SAPK/JNKs and p38 MAPK) in perfused rat hearts by oxidative and other stresses
20. The activation state of p38 MAP kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding
21. A synthetic inhibitor of the mitogen-activated protein kinase cascade
22. 2B receptors
23. Comparative effects of angiotensin-converting enzyme inhibition and angiotensin II type I receptor blockade on cardiac remodeling after myocardial infarction in the rat
24. Angiotensin-converting enzyme inhibition prevents the increase in aortic collagen in rats
25. Selective activation of p38 MAP kinase isoforms by the MAP kinase kinases MKK3 and MKK6
26. Stress-response MAPK (JNK, and p38 MAPK) in the myocardium
27. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 MAP kinase family
28. p38 MAPK is a critical component of the redox-sensitive signaling pathways activated by Ang II
29. Differential activation of MAP kinases in smooth muscle cells by Ang II: Involvement of p22phox and reactive oxygen species
30. JunB forms the majority of the AP-I complex and is a target for redox regulation by receptor tyrosine kinase and g protein-coupled receptor agonists in smooth muscle cells
31. 2 in angiotensin II-induced vascular hypertrophy
32. Ang II-induced superoxide production is mediated via phospholipase D in human vascular smooth muscle cells
33. Vascular Ang II receptors in SHR
34. 2 receptors in Ang II-stimulated contraction of small mesenteric arteries in young SHR
35. 1 receptors in vascular smooth muscle cells from WKY and SHR